ISOPP CAPhO 2025 Symposium: Opportunistic Infection Management in Hematologic Malignancies: A Focus on CMV Management

Cytomegalovirus is one of the most important infections that occur after allogeneic hematopoietic stem cell transplantation, and an increasing number of reports indicate that cytomegalovirus is a potentially important pathogen in patients treated with newer pharmacotherapies for hematologic malignancies. This presentation will focus on the pathogenesis of cytomegalovirus, strategies to prevent cytomegalovirus, as well as evidence-based recommendations for treatment of cytomegalovirus in patients with hematologic malignancies.

Learning Objectives

• Explain the pathogenesis of cytomegalovirus (CMV) in patients with hematologic malignancies and after hematopoietic stem cell transplantation.
• Identify approaches to prevent CMV after hematopoietic stem cell transplantation.
• Describe current pharmacotherapies to manage CMV.